Cargando…

In Vivo Tissue Pharmacokinetics of Carbon-11-Labeled Clozapine in Healthy Volunteers: A Positron Emission Tomography Study

We investigated clozapine (CLZ) tissue pharmacokinetics in vivo by using carbon-11-labeled CLZ ((11)C-CLZ) and positron emission tomography (PET). Eight healthy volunteers underwent (11)C-CLZ studies wherein computed tomography image acquisition was followed by PET scans (whole-body, four; brain, fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, HS, Kim, E, Moon, BS, Lim, NH, Lee, BC, Kim, SE
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452936/ https://www.ncbi.nlm.nih.gov/pubmed/26225256 http://dx.doi.org/10.1002/psp4.38

Ejemplares similares

A combined accelerator mass spectrometry/positron emission tomography microdose study to assess the plasma and brain tissue pharmacokinetics of (11)C- and (14)C-labelled verapamil in healthy volunteers
por: Wagner, Claudia C, et al.
Publicado: (2008)

Associations Between Cognition and Serotonin 1B Receptor Availability in Healthy Volunteers: A [(11)C]AZ10419369 Positron Emission Tomography Study
por: Tangen, Ämma, et al.
Publicado: (2022)

A single‐center, open‐label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers
por: Finnema, Sjoerd J., et al.
Publicado: (2019)

Bilastine vs. hydroxyzine: occupation of brain histamine H(1)-receptors evaluated by positron emission tomography in healthy volunteers
por: Farré, Magí, et al.
Publicado: (2014)

A generic (89)Zr labeling method to quantify the in vivo pharmacokinetics of liposomal nanoparticles with positron emission tomography
por: Li, Nan, et al.
Publicado: (2017)

A novel (11)C-labeled thymidine analog, [(11)C]AZT, for tumor imaging by positron emission tomography
por: Tahara, Tsuyoshi, et al.
Publicado: (2015)

Automated synthesis of radiopharmaceuticals for positron emission tomography: an apparatus for labelling with [(11)C] methyl iodide (MIASA)
por: Cork, D. G., et al.
Publicado: (1994)

Automated synthesis of radiopharmaceuticals for positron emission tomography: an apparatus for [1-(11)C] labeled carboxylic acid
por: Yajima, Kazuyoshi, et al.
Publicado: (1995)

Carbon-11 and Fluorine-18 Labeled Amino Acid Tracers for Positron Emission Tomography Imaging of Tumors
por: Sun, Aixia, et al.
Publicado: (2018)

Simultaneous Photoradiochemical Labeling of Antibodies for Immuno-Positron Emission Tomography
por: Patra, Malay, et al.
Publicado: (2019)

Intelligent Labeling of Tumor Lesions Based on Positron Emission Tomography/Computed Tomography
por: Ye, Shiping, et al.
Publicado: (2022)

Positron emission tomography
Publicado: (1995)

Positron Emission Tomography
por: Piepmeier, Joseph M.
Publicado: (1986)

Positron emission tomography
por: Paans, A M J
Publicado: (2006)

Radiosynthesis, Preclinical, and Clinical Positron Emission Tomography Studies of Carbon-11 Labeled Endogenous and Natural Exogenous Compounds
por: Shegani, Antonio, et al.
Publicado: (2022)

Development of Novel (11)C-Labeled Selective Orexin-2 Receptor Radioligands for Positron Emission Tomography Imaging
por: Rong, Jian, et al.
Publicado: (2023)

An open-label, positron emission tomography study of the striatal D(2)/D(3) receptor occupancy and pharmacokinetics of single-dose oral brexpiprazole in healthy participants
por: Wong, Dean F., et al.
Publicado: (2020)

Pharmacokinetic Interactions Between Bazedoxifene and Cholecalciferol: An Open-Label, Randomized, Crossover Study in Healthy Male Volunteers
por: Lee, Moon Hee, et al.
Publicado: (2023)

Tissue pharmacokinetics of DHP107, a novel lipid‐based oral formulation of paclitaxel, in mice and patients by positron emission tomography
por: Moon, Byung Seok, et al.
Publicado: (2021)

(11)C-acetate and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization
por: Park, Sohyun, et al.
Publicado: (2018)

Correction to: An open-label, positron emission tomography study of the striatal D(2)/D(3) receptor occupancy and pharmacokinetics of single-dose oral brexpiprazole in healthy participants
por: Wong, Dean F., et al.
Publicado: (2021)

Radiosynthesis and Evaluation of [(11)C-Carbonyl]-Labeled Carbamates as Fatty Acid Amide Hydrolase Radiotracers for Positron Emission Tomography
por: Wilson, Alan A., et al.
Publicado: (2012)

Synthesis and Evaluation of (11)C-Labeled Triazolones as Probes for Imaging Fatty Acid Synthase Expression by Positron Emission Tomography
por: Kelly, James M., et al.
Publicado: (2022)

Correction to “Radiosynthesis, Preclinical and Clinical Positron Emission Tomography Studies of Carbon-11 Labeled Endogenous and Natural Exogenous Compounds”
por: Shegani, Antonio, et al.
Publicado: (2023)

Positron emission tomography: An overview
por: Shukla, A. K., et al.
Publicado: (2006)

Scintillators for positron emission tomography
por: Moses, W W, et al.
Publicado: (1995)

Detectors in positron emission tomography
por: Zatcepin, Artem, et al.
Publicado: (2022)

Radiochemistry for positron emission tomography
por: Rong, Jian, et al.
Publicado: (2023)

Effect of Rifampicin on the Pharmacokinetics of Evogliptin in Healthy Volunteers
por: Shin, Yesong, et al.
Publicado: (2022)

Fatty Acid Amide Hydrolase Inhibition by JNJ‐42165279: A Multiple‐Ascending Dose and a Positron Emission Tomography Study in Healthy Volunteers
por: Postnov, Andrey, et al.
Publicado: (2018)

Feasibility of subendocardial and subepicardial myocardial perfusion measurements in healthy normals with (15)O-labeled water and positron emission tomography
por: Vermeltfoort, Ilse A., et al.
Publicado: (2011)

Quantitative accuracy of positron emission tomography/magnetic resonance and positron emission tomography/computed tomography for cervical cancer
por: Oldan, Jorge Daniel, et al.
Publicado: (2018)

Population Pharmacokinetic and Pharmacodynamic Modeling Analysis of GCC‐4401C, a Novel Direct Factor Xa Inhibitor, in Healthy Volunteers
por: Choi, HY, et al.
Publicado: (2016)

Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography
por: Therriault, Joseph, et al.
Publicado: (2022)

Pharmacokinetics of Oral Taurine in Healthy Volunteers
por: Ghandforoush-Sattari, Mohammadreza, et al.
Publicado: (2010)

Pharmacokinetics of chloroquine and primaquine in healthy volunteers
por: Daher, André, et al.
Publicado: (2022)

Pharmacokinetics of intranasal amiloride in healthy volunteers
por: Yellepeddi, Venkata K., et al.
Publicado: (2023)

In vivo imaging of invasive aspergillosis with (18)F-fluorodeoxysorbitol positron emission tomography
por: Kim, Dong-Yeon, et al.
Publicado: (2022)

Site-Specific Labeling of scVEGF with Fluorine-18 for Positron Emission Tomography Imaging
por: Wang, Hui, et al.
Publicado: (2012)

Imaging of Pseudomonas aeruginosa infection with Ga-68 labelled pyoverdine for positron emission tomography
por: Petrik, Milos, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5i45875rgvhluljfg8vqar6afu